Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome

Detalles Bibliográficos
Autores principales: Okour, Malek, Al-Kofahi, Mahmoud, Austin, Daren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220612/
https://www.ncbi.nlm.nih.gov/pubmed/32405664
http://dx.doi.org/10.1007/s10928-020-09689-x
_version_ 1783533201779589120
author Okour, Malek
Al-Kofahi, Mahmoud
Austin, Daren
author_facet Okour, Malek
Al-Kofahi, Mahmoud
Austin, Daren
author_sort Okour, Malek
collection PubMed
description
format Online
Article
Text
id pubmed-7220612
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-72206122020-05-14 Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome Okour, Malek Al-Kofahi, Mahmoud Austin, Daren J Pharmacokinet Pharmacodyn Commentary Springer US 2020-05-13 2020 /pmc/articles/PMC7220612/ /pubmed/32405664 http://dx.doi.org/10.1007/s10928-020-09689-x Text en © Springer Science+Business Media, LLC, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Commentary
Okour, Malek
Al-Kofahi, Mahmoud
Austin, Daren
Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome
title Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome
title_full Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome
title_fullStr Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome
title_full_unstemmed Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome
title_short Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome
title_sort hydroxychloroquine and azithromycin as potential treatments for covid-19; clinical status impacts the outcome
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220612/
https://www.ncbi.nlm.nih.gov/pubmed/32405664
http://dx.doi.org/10.1007/s10928-020-09689-x
work_keys_str_mv AT okourmalek hydroxychloroquineandazithromycinaspotentialtreatmentsforcovid19clinicalstatusimpactstheoutcome
AT alkofahimahmoud hydroxychloroquineandazithromycinaspotentialtreatmentsforcovid19clinicalstatusimpactstheoutcome
AT austindaren hydroxychloroquineandazithromycinaspotentialtreatmentsforcovid19clinicalstatusimpactstheoutcome

Ejemplares similares